TheraSource

Feinstein, TheraSource target sepsis, with NIH’s help

By GREGORY ZELLER // With a little help from the besieged National Institutes of Health, a pillar of Long Island-based scientific research and one of its shining biotech spinoffs are taking the fight to a modern-medicine scourge responsible for some 500,000 U.S. deaths each year. The Feinstein Institute for Medical Research, the R&D division of the Northwell Health system, and Manhasset-based TheraSource LLC, a circa-2004 biopharma spun out of the Feinstein Institute, announced this week…


TheraSource snags $3M SBIR grant

By GREGORY ZELLER // A Feinstein Institute-born biotech will tackle radiation poisoning thanks to a grant from the National Institute of Allergy and Infectious Diseases. TheraSource, a Manhasset-based 2004 startup spun out of Northwell Health’s Feinstein Institute for Medical Research, has received a $3 million, three-year Small Business Innovation Research grant from the NIAID, part of the National Institutes of Health. The grant will support the development of an innovative treatment to alleviate physical damage…